SCHEMBL12428330

SCHEMBL12428330

CCCCCCCCN1CCCCc2cc(/C=C/C=C3\C(=O)N(c4ccccc4)N=C3C(=O)O)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 15/20 0.39
MAPT P10636 13/20 0.39
ALDH1A1 P00352 13/20 0.39
MEN1 O00255 12/20 0.39
MAPK1 P28482 6/20 0.39
HTT P42858 5/20 0.39
MDM2 Q00987 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
L3MBTL1 Q9Y468 6/20 0.39
TDP1 Q9NUW8 5/20 0.39
LMNA P02545 4/20 0.39
POLB P06746 4/20 0.39
PKM P14618 1/20 0.37
OPRK1 P41145 1/20 0.37
KDM4E B2RXH2 8/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428485 0.98 KMT2A (0.42) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12428295 0.94 APOBEC3A (0.41) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12510314 0.89 KMT2A (0.46) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12428339 0.87 ADRB2 (0.40) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12428196 0.85 ADRB2 (0.40) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12428229 0.84 KMT2A (0.47) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL13866486 0.83 ADRB2 (0.44) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12428331 0.82 KMT2A (0.47) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12428386 0.81 MAPT (0.38) KMT2AMAPTALDH1A1MEN1MAPK1
SCHEMBL12428321 0.81 KMT2A (0.43) KMT2AMAPTALDH1A1MEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 KMT2A 105/4885MAPT 4642/4885ALDH1A1 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.